Bullfrog AI Holdings, Inc. (NASDAQ:BFRG – Get Free Report) was the target of a large growth in short interest in the month of April. As of April 15th, there was short interest totalling 501,500 shares, a growth of 47.7% from the March 31st total of 339,500 shares. Based on an average trading volume of 1,010,000 shares, the days-to-cover ratio is presently 0.5 days. Currently, 7.3% of the company’s stock are sold short.
Bullfrog AI Stock Performance
NASDAQ:BFRG opened at $1.81 on Wednesday. The stock has a market capitalization of $17.04 million, a P/E ratio of -2.13 and a beta of 0.77. The company’s 50-day simple moving average is $1.81 and its 200-day simple moving average is $2.21. Bullfrog AI has a fifty-two week low of $1.23 and a fifty-two week high of $4.84.
Bullfrog AI (NASDAQ:BFRG – Get Free Report) last released its quarterly earnings results on Friday, March 14th. The company reported ($0.18) earnings per share (EPS) for the quarter.
Insider Activity
Institutional Investors Weigh In On Bullfrog AI
Hedge funds and other institutional investors have recently added to or reduced their stakes in the business. Geode Capital Management LLC increased its holdings in shares of Bullfrog AI by 31.0% during the fourth quarter. Geode Capital Management LLC now owns 47,093 shares of the company’s stock valued at $94,000 after acquiring an additional 11,140 shares in the last quarter. Raymond James Financial Inc. acquired a new position in Bullfrog AI during the 4th quarter valued at approximately $30,000. Finally, Two Sigma Securities LLC purchased a new position in shares of Bullfrog AI in the fourth quarter worth $41,000. 0.96% of the stock is currently owned by hedge funds and other institutional investors.
About Bullfrog AI
Bullfrog AI Holdings, Inc, through its subsidiaries, operates as a digital biopharmaceutical company that focuses on artificial intelligence and machine learning (AI/ML) driven analysis of data sets in medicine and healthcare in the United States. The company offers bfLEAP, an analytical AI/ML platform for the analysis of preclinical and/or clinical data.
Featured Articles
- Five stocks we like better than Bullfrog AI
- Learn Technical Analysis Skills to Master the Stock Market
- Don’t Be Fooled by the Bounce: The Market Storm Isn’t Over Yet
- High Flyers: 3 Natural Gas Stocks for March 2022
- Coca-Cola Company Stock Can Bubble to New Highs This Year
- Dividend Screener: How to Evaluate Dividend Stocks Before Buying
- 3 Stocks Lifting 2025 Guidance Despite Market Jitters
Receive News & Ratings for Bullfrog AI Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bullfrog AI and related companies with MarketBeat.com's FREE daily email newsletter.